MTOR and mantle cell lymphoma: Here, it is also worth mentioning that ibrutinib-resistant MCL samples upregulate the mTOR signaling pathway (as well as genes involved in cell cycle regulation and MYC targets) compared to ibrutinib-sensitive cells (87).